Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;16(1):125-144.
doi: 10.1016/j.jsmc.2020.10.007. Epub 2020 Dec 15.

Where to Next for Optimizing Adherence in Large-Scale Trials of Continuous Positive Airway Pressure?

Affiliations
Review

Where to Next for Optimizing Adherence in Large-Scale Trials of Continuous Positive Airway Pressure?

Amy M Sawyer et al. Sleep Med Clin. 2021 Mar.

Abstract

Large-scale randomized trials of positive airway pressure (PAP) efficacy have been largely negative but PAP adherence was notably suboptimal across the trials. To address this limitation, evidence-based PAP adherence protocols embedded within the larger trial protocol are recommended. The complexity of such protocols depends on adequacy of resources, including funding and inclusion of behavioral scientist experts on the scientific team, and trial-specific considerations (eg, target population) and methods. Recommendations for optimizing PAP adherence in large-scale trials are set forth that address rigor and reproducibility.

Keywords: Behavioral economics; Continuous positive airway pressure; Controlled clinical trial; Health behavior; Health education; Obstructive sleep apnea; Patient compliance; Telemedicine.

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr A.M. Sawyer has received grant support from NIH, American Nurses Foundation, American Lung Association, and VA HSR&D. Dr D.M. Wallace has no disclosures. Dr L.F. Buenaver discloses grant support from NIH and American Sleep Medicine Foundation. Ms A. Blase is an employee of ResMed Corp. Dr A.J. Watach discloses research training support from NIH (HL07953). Mr B. Saconi has no disclosures. Dr S.R. Patel discloses grant support from NIH (DK120051) and has received grant support from NIH, Bayer Pharmaceuticals, Philips Respironics, and Respicardia. Dr S.T. Kuna discloses grant support from NIH (DK120051). Dr N.M. Punjabi discloses grant support from NIH (NL117167, HL146709, DK120051) and from ResMed and Philips Respironics to Johns Hopkins University.

MeSH terms

LinkOut - more resources